]>
IRCT20200921048783N1 IRCT 2020-12-06 Abadan University of Medical Sciences Effect of GRAPEX in treatment of COVID-19 Effect of Grapex on the alternations of clinical symptoms and laboratory finding on COVID19. 2021-01-08 anticipated 80 Complete https://irct.ir/trial/51199 interventional Randomization: Randomized, Blinding: Double blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Block randomization, Blinding description: Patients and researchers are blinded as double blind. 3 covid19. Intervention 1: Intervention group: Patients receiving standard country protocol drugs with Grapex 200 mg twice a day until the patient's clinical symptoms improve . Intervention 2: Control group: Patients receiving standard country protocol drugs with placebo twice a day until the patient's clinical symptoms improve . Yes - There is a plan to make this available What will be shared: All data can be shared after the participants in the study are unrecognizable. When: The data access period after printing the article To whom: The data in this study will be available to researchers working at academic and scientific institutions, as well as the Food and Drug Administration. Conditions: Any analysis can be done with the consent of the main researcher. Where to obtain: dr.mojiri@yahoo.com How to obtain: The researcher or pharmaceutical company can send their request to the academic email after sending the documents to confirm their original identity.The project manager will then provide the requested information to the researcher or pharmaceutical company after ensuring the accuracy of the submitted documents after a period of one week. Comments:
public Hoda Mojiri-Forushani
Abadan School of Medical Sciences,Beginning of the 30 meters Ave, Zolfaghari street, Abadan city.
Abadan Iran (Islamic Republic of) 6313833177 +98 61 5338 4004 dr.mojiri@yahoo.com Abadan University of Medical Sciences scientific Hoda Mojjiri-Forushani
Abadan School of Medical Sciences, Beginning of the street 30 meters Ave, Zolfaghari street, Abadan city.
Abadan Iran (Islamic Republic of) 631911154 +98 61 5338 4004 dr.mojiri@yahoo.com Abadan University of Medical Sciences Iran (Islamic Republic of) Patients diagnosed with covid19 by positive PCR test. Patients diagnosed with covid19 by positive CT scan evaluation no limit no limit Both U07 Other coronavirus as the cause of diseases classified elsewhere Treatment - Drugs Placebo Intervention group: Patients receiving standard country protocol drugs with Grapex 200 mg twice a day until the patient's clinical symptoms improve . Control group: Patients receiving standard country protocol drugs with placebo twice a day until the patient's clinical symptoms improve . Time to clinical alternations defined as start of taking medication time to Discharge Time. Timepoint: The beginning of the study ,the seventh day, the fourteenth day, the twenty-first day, the twenty-eighth day. Method of measurement: Medical record. Complete Blood Count. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. C-reactive-protein. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. SER. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. Creatinine. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. Aspartate amino transferase. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. Alanine amino transferase. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. Prothrombin time. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. Partial Thromboplastin time. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. Cough. Timepoint: The beginning of the study ,the seventh day, the fourteenth day. Method of measurement: Clinical observation and examination. Level of consciousness. Timepoint: The beginning of the study ,the seventh day, the fourteenth day. Method of measurement: Using the Glasgow Coma scale. Arterial oxygen saturation. Timepoint: The beginning of the study ,the seventh day, the fourteenth day. Method of measurement: Blood sample. Blood pressure. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Clinical examination. Level of serum sodium. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. Level of serum potassium. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. BUN. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. INR. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. Mortality rate. Timepoint: Daily. Method of measurement: Blood sample. Number of days of hospitalization. Timepoint: Daily. Method of measurement: Medical record. Alkaline phosphatase. Timepoint: The beginning of the study and the time of discharge. Method of measurement: Blood sample. Abadan University of Medical Sciences Approved 2020-08-25 Ethics committee of Abadan school of Medical Sciences Abadan School of Medical Sciences,Beginning of the 30 meters Ave, Zolfaghari street, Abadan city. Abadan Khouzestan Iran (Islamic Republic of)